Plew Danielp Van News Today

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twenty-six brokerages that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and nineteen have issued a buy recommendation on the […]

Activest Wealth Management bought a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 51 shares of the biopharmaceutical company’s stock, valued at approximately $40,000. Other institutional investors and hedge funds have also recently added […]

Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the twenty-seven brokerages that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and twenty have given a buy rating to the […]

Bank Julius Baer & Co. Ltd Zurich raised its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 91,386.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 74,501,081 shares of the biopharmaceutical company’s stock after buying […]

ICICI Prudential Asset Management Co Ltd lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 733 shares of the biopharmaceutical company’s stock after buying an additional 45 shares during […]

Veracity Capital LLC boosted its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.3% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 6,518 shares of the biopharmaceutical company’s stock after purchasing an additional 17 shares during the quarter. Regeneron Pharmaceuticals […]

Penbrook Management LLC lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,022 shares of the biopharmaceutical company’s stock after selling 50 shares during […]

Schaper Benz & Wise Investment Counsel Inc. WI increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 18,014 shares of the biopharmaceutical company’s stock after acquiring an additional […]

Warther Private Wealth LLC raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.6% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 3,594 shares of the biopharmaceutical company’s stock after purchasing an additional 55 shares during the period. Regeneron Pharmaceuticals accounts for approximately […]

Two Sigma Advisers LP boosted its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 332.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 209,800 shares of the biopharmaceutical company’s stock after purchasing an additional 161,300 […]